Regulatory clearance opens the way for new single-size contraceptive diaphragm in the US

September 9, 2014, PATH

The United States Food and Drug Administration (USFDA) has cleared the Caya contoured diaphragm for marketing in the United States, bringing women one step closer to a new option for safe and effective non-hormonal contraception. The Caya contoured diaphragm is expected to be available to US consumers within the next year. Its clearance by the USFDA is also important for increasing women's access to non-hormonal contraceptive options worldwide because USFDA approval is a gold standard of regulatory approval globally. The USFDA decision follows approval of the Caya contoured diaphragm by European and Canadian regulatory authorities in 2013 and early 2014, respectively.

The Caya contoured diaphragm—called the SILCS Diaphragm during design and clinical validation stages—was developed by PATH, CONRAD, and partners at multiple sites through a user-centered process. Feedback from women, their partners, and health care providers from four countries helped refine the design and resulted in special features that make this single-size non-latex diaphragm simple to provide and easy to use. In clinical studies comparing the SILCS Diaphragm to a traditional diaphragm, women preferred the SILCS Diaphragm for its ease of handling. A recent contraceptive effectiveness study implemented by CONRAD confirmed the SILCS Diaphragm was as effective as a traditional diaphragm when each is used with contraceptive gel. The development and testing of the SILCS Diaphragm was supported with funds from the United States Agency for International Development (USAID) and private foundations.

In 2010, PATH licensed the SILCS Diaphragm technology to Kessel medintim GmbH (Kessel), a privately held German company that manufactures and distributes sexual and products. Kessel now markets the SILCS Diaphragm as the Caya contoured diaphragm in 14 European countries and Canada via family planning providers, pharmacies, and online shops. With USFDA clearance, Kessel will seek a distribution partner to introduce the Caya contoured diaphragm in the United States through family planning providers. PATH and its partners are working to bring the Caya contoured diaphragm to developing countries as well.

"This approval represents a significant and hard-earned milestone in the global effort to expand women's contraceptive options," said Steve Davis, PATH president and CEO. "It demonstrates the best of what multi-sector collaboration can achieve when we harness our shared expertise to develop solutions that can improve the health of women and their families around the world."

CONRAD conducted clinical studies that validated the safety, acceptability, and effectiveness of the Caya contoured diaphragm for women, helping facilitate US market clearance. "Thanks to the unique design, it fits most women, and a pelvic exam is not required for a fitting, thus making access to this new option for birth control much easier," said Gustavo Doncel, MD, PhD, Scientific and Executive Director of CONRAD. "CONRAD has a long history of collaborating with organizations like PATH to create new methods of contraception and HIV prevention for women."

Ellen Starbird, Director of USAID's Office of Population and Reproductive Health: "USAID has supported the SILCS Diaphragm from the early days of its development, and we are pleased to see this new contraceptive technology cleared for marketing by the USFDA. We see new technologies, like the SILCS Diaphragm, as essential to meet global family planning goals, including reaching 120 million more women and girls with information and services by 2020."

Worldwide, there are many reasons why women who do not want to become pregnant are not using existing contraceptive methods. These include concerns about the side effects of hormonal contraception, preference for a method that can be used only when needed, and challenges with negotiating condom use with partners. Furthermore, women often have difficulty reaching a health care provider to discuss, initiate, or maintain other methods. The Caya contoured diaphragm could help address the needs of these women.

"This woman-initiated, non-hormonal contraceptive barrier method has great potential to improve women's reproductive health options by addressing several of the reasons for unmet contraceptive need," said Judy Manning, of the team for contraceptive research and development at USAID. Manning added that the device may fill another needed role by "serving as a delivery method for gels that help protect against HIV and other sexually transmitted infections—it could be our first true multipurpose prevention product."

The innovative single-size diaphragm was developed to expand women's options for non-hormonal barrier contraception, especially in developing countries where diaphragms are not available. PATH and its partners recognize that US consumers may also be interested in an improved diaphragm designed for ease of use and comfort, and USFDA market clearance helps pave the way for future availability.

"It is vitally important to expand access in the United States to methods that expand 's pregnancy and STI prevention options," said Wayne C. Shields, President and CEO at the Association of Reproductive Health Professionals (ARHP). "ARHP supports the availability of as many safe, effective prevention options as possible, since each woman's sexual and reproductive health needs are unique and vary over her life span."

Explore further: Women and health-care providers differ on what matters most about contraception

Related Stories

Women and health-care providers differ on what matters most about contraception

June 9, 2014
When women are choosing a contraceptive, health care providers should be aware that the things they want to discuss may differ from what women want to hear, according to a survey published in the recent issue of the journal ...

Hormonal contraception may up gestational diabetes risk

July 25, 2014
(HealthDay)—The type of contraceptives used before pregnancy may influence the risk of gestational diabetes mellitus (GDM), according to research published July 17 in Preventing Chronic Disease.

Attention to postpartum contraception needed

April 2, 2014
(HealthDay)—Women in the postpartum period should receive counseling and access to contraceptive methods to promote optimal birth spacing, according to research published in the April issue of the American Journal of Obstetrics ...

Women will benefit from the Affordable Care Act's contraceptive coverage

August 19, 2014
Women could benefit greatly from the Affordable Care Act's mandate for contraceptive coverage, according to Penn State College of Medicine researchers.

Positive results of Phase 3 trial of 1-year contraceptive vaginal ring presented

October 16, 2013
Today, the Population Council presented findings from a Phase 3 clinical trial that was designed to demonstrate the safety, efficacy, and acceptability of the Council's investigational one-year contraceptive vaginal ring ...

Unplanned pregnancy remains high among young Australian women

April 2, 2014
Despite high rates of contraceptive use, unwanted pregnancies resulting in terminations remain high among young women.

Recommended for you

One in four U.S. adults sits more than eight hours a day

November 20, 2018
(HealthDay)—Couch Potato Nation: Nearly half of Americans sit for far too many hours a day and don't get any exercise at all, a new study finds.

Sugar-sweetened beverages are harmful to health and may be addictive, researchers suggest

November 20, 2018
Just as we might have guessed, those tasty, sugar-sweetened beverages that increase risk of diabetes and other chronic diseases may actually be addictive. Youth between 13 and 18 years of age who were deprived of sugary drinks ...

Teen personality traits linked to risk of death from any cause 50 years later

November 20, 2018
Personality traits evident as early as the teenage years may be linked to a heightened or lessened risk of death around 50 years later, suggests observational research of 'baby boomers,' published online in the Journal of ...

Emotional abuse may be linked with menopause misery

November 19, 2018
Smoking, obesity and a sedentary lifestyle have long been linked to heightened symptoms of menopause. Now, a study headed by UC San Francisco has identified another factor that may add to menopause torment: an emotionally ...

How AI could help veterinarians code their notes

November 19, 2018
A team led by scientists at the School of Medicine has developed an algorithm that can read the typed-out notes from veterinarians and predict specific diseases that the animal may have.

Bullying and violence at work increases the risk of cardiovascular disease

November 19, 2018
People who are bullied at work or experience violence at work are at higher risk of heart and brain blood vessel problems, including heart attacks and stroke, according to the largest prospective study to investigate the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.